Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through ...

Guardant Health Expands Cancer Testing Platform With MetaSight Deal And Shield Growth

Guardant Health (NasdaqGS:GH) agreed to acquire MetaSight Diagnostics, expanding its liquid biopsy capabilities into early ...
Seeking Alpha

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States

Collaboration to enable streamlined and accelerated access to Shield blood-based colorectal cancer screening test across Quest’s vast network Shield is the first and only blood test to receive full ...
Homeland Security Today

OMNIQ’s Artificial Intelligence-Based Quest Shield Solution Selected by the Talmudical Academy of Baltimore

OMNIQ, Inc. announces that it has been selected to deploy its Quest Shield™ campus safety solution at the Talmudical Academy of Baltimore in Maryland. The Quest Shield™ security package uses the ...